CANCERS

Clinical trials for CANCERS explained in plain language.

Never miss a new study

Get alerted when new CANCERS trials appear

Sign up with your email to follow new studies for CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Terminated 1

New drug NM6603 enters first human tests for advanced cancers

Disease control Recruiting now

This early-stage study tests a new drug called NM6603 in about 30 adults with advanced solid tumors (mainly colorectal or triple-negative breast cancer) who have run out of standard options. The main goal is to find the safest dose and check how the drug moves through the body. P…

Matched conditions: CANCERS

Phase: PHASE1 • Sponsor: NucMito Pharmaceuticals Co. Ltd. • Aim: Disease control

Last updated Jun 27, 2026 08:11 UTC

CANCERS

Get alerted when new CANCERS trials appear

New drug NM6603 enters first human tests for advanced cancers